Potentiation of neuronal nicotinic acetylcholine receptors by exogenous ligands is a promising strategy for treatment of neurological disorders including Alzheimer's disease and schizophrenia. To gain insight into molecular mechanisms underlying potentiation, we examined ACh-induced single-channel currents through the human neuronal ␣7 acetylcholine receptor in the presence of the ␣7-specific potentiator PNU-120596 (PNU). Compared to the unusually brief single-channel opening episodes elicited by agonist alone, channel opening episodes in the presence of agonist and PNU are dramatically prolonged. Dwell time analysis reveals that PNU introduces two novel components into open time histograms, indicating at least two degrees of PNU-induced potentiation. Openings of the longest potentiated class coalesce into clusters whose frequency and duration change over a narrow range of PNU concentration. At PNU concentrations approaching saturation, these clusters last up to several minutes, prolonging the submillisecond ␣7 opening episodes by several orders of magnitude. Mutations known to reduce PNU potentiation at the whole-cell level still give rise to multisecond-long single-channel clusters. However mutation of five residues lining a cavity within each subunit's transmembrane domain abolishes PNU potentiation, defining minimal structural determinants of PNU potentiation.
Introduction
Neuronal ␣7 nicotinic acetylcholine receptors belong to the Cysloop superfamily of pentameric ligand-gated ion channels and mediate synaptic transmission in many brain regions. High levels of ␣7 expression in both hippocampus and cerebral cortex suggest contributions to higher brain functions such as memory and learning (Dani and Bertrand, 2007) . Furthermore, impaired ␣7 signaling has been implicated in cognitive deficits associated with Alzheimer's disease and schizophrenia (Freedman et al., 1995 (Freedman et al., , 1997 Qi et al., 2007) . As a result, ␣7 is a potential therapeutic target for offsetting the effects of cognitive decline (Leiser et al., 2009; Taly et al., 2009; Hajó s and Rogers, 2010; Haydar and Dunlop, 2010; Williams et al., 2011) .
Because coordination of synaptic events is crucial in neuronal communication, an ideal therapeutic approach would augment the strength of an existing synapse without disrupting temporal control provided by an endogenous neurotransmitter. At the single ion channel level, this would require a drug that does not activate the channel by itself but instead modifies the agonistinduced responses (Maelicke and Albuquerque, 1996; Hogg et al., 2005) . Compounds that potentiate agonist responses have been called positive allosteric modulators (PAMs), while those that attenuate responses have been called negative allosteric modulators (Bertrand and Gopalakrishnan, 2007) .
Several ␣7 PAMs, ranging in potency and specificity, have been identified (Faghih et al., 2008; Lightfoot et al., 2008; Arias, 2010; Williams et al., 2011) . Of these, PNU-120596 (PNU) has garnered significant attention, largely because in vivo studies demonstrate that systemic administration of PNU alleviates cognitive impairment in rats (Hurst et al., 2005) . Electrophysiological measurements of macroscopic currents show that whereas PNU alone fails to trigger ␣7 current, application of PNU with agonist dramatically increases the magnitude and duration of agonist-induced currents (Hurst et al., 2005) . Furthermore, PNU is specific for ␣7 in that it does not potentiate other members of the Cys-loop receptor superfamily. Studies exploiting this specificity used chimeric receptors to identify regions within the transmembrane (TM) domain of ␣7 that are important for PNU potentiation (Bertrand et al., 2008; Young et al., 2008) . Those observations, combined with docking simulations, suggest PNU binds to an intrasubunit cavity within the TM domain of ␣7 (Young et al., 2008) .
While the effects of PNU on ␣7 have been studied at the macroscopic/whole-cell level, little is known about the effects at the microscopic/single-channel level. Initial studies showed that PNU did not increase single-channel conductance (Hurst et al., 2005) . Instead, agonists elicited longer channel openings when applied in the presence of PNU (Hurst et al., 2005; Gusev and Uteshev, 2010) . To gain more definitive insight, we here examine the effects of PNU on single-channel currents through human ␣7 acetylcholine receptors expressed in HEK 293 cells. We find that mutations known to reduce PNU potentiation of whole-cell currents still potentiate single-channel currents. By exploiting the sensitivity of single-channel recording, we identify a quintuple mutant for which PNU potentiation is essentially abolished. This mutant includes novel mutations that together with previously characterized mutations define structural determinants of PNU potentiation.
Materials and Methods
Materials. 1-(5-Chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea, known as PNU-120596, was from Tocris Biosciences.
125 I-␣-Bungarotoxin (␣-BTX) was from PerkinElmer. All other chemicals, including acetylcholine chloride (ACh), were from Sigma-Aldrich.
Site-directed mutagenesis and human ␣7 expression. Mutant ␣7 cDNAs were constructed using the QuikChange Site-Directed Mutagenesis kit (Stratagene) and then confirmed by sequencing the entire coding region. BOSC 23 cells, modified HEK 293 cells (Pear et al., 1993) , were transfected by calcium phosphate precipitation as described previously (Sine, 1993; Bouzat et al., 1994; Sine et al., 1994) . Furthermore, expression of human ␣7 (GenBank accession number X70297) in mammalian cells lines requires cotransfection with the intracellular chaperone Ric-3 (Williams et al., 2005) . Ric-3 and ␣7 DNA were cotransfected at a ratio of 12:1 (w/w), with the total ␣7 DNA ranging from ϳ0.02 to 1 g for a 35 mm culture dish. Transfections in DMEM with 10% fetal bovine serum were carried out between 3 and 12 h and terminated by exchanging the medium. Because some conditions benefitted from a large number of channels in the patch (i.e., no PNU), and others from relatively few channels (i.e., Ն1 M PNU), the expression level of ␣7 was manipulated by adjusting the transfection time and DNA concentration during transfection, as well as time after transfection. Cells were used for either whole-cell or single-channel recordings 0.5-7 d posttransfection. To facilitate identification of transfected cells, a separate plasmid encoding green fluorescent protein was included in all transfections.
Patch-clamp recordings. Macroscopic currents were recorded in the whole-cell configuration at a holding potential of Ϫ50 mV, filtered at 5 kHz, digitized at 20 kHz, and analyzed using the IgorPro software (WaveMetrics). The pipette solution contained 134 mM KCl, 5 mM EGTA, 1 mM MgCl 2 , and 10 mM HEPES, pH 7.3. The extracellular solution (ECS) contained the following (in mM): 150 NaCl, 1.8 CaCl 2 , 1 MgCl 2 , and 10 HEPES, pH 7.4. The perfusion system consisted of solution reservoirs, manual switching valves, a four-channel valve controller (ALA Scientific Instruments), a solenoid-driven pinch valve, and two tubes (inner diameter, 0.3 mm), orientated at 90°, inserted into the culture dish (Liu and Dilger, 1991; Bouzat et al., 2008) . For control responses, one tube contained ECS without agonist and the other contained ECS with ACh. The solution exchange time was estimated by applying ECS diluted 1:2 with water and varied between 0.1 and 1 ms (Bouzat et al., 2008; Corradi et al., 2009) . Each current trace presented is the ensemble average of 3-5 individual traces obtained from the same cell that were aligned at the point where the current reached 50% of the peak current. Macroscopic responses were recorded using the following protocol of PNU application. First, the cell was exposed to ECS, followed by a 1.5 s pulse of ECS containing 100 M ACh (first control). The same cell was then preincubated for 1 min with ECS containing 3 M PNU before applying a 1.5 s pulse of ECS containing both 100 M ACh and 3 M PNU. The stability of the seal and the reversibility of the PNU effect was confirmed by washing the cell for 1 min with ECS and then applying another 1.5 s pulse of ECS containing 100 M ACh (second control).
Single-channel recordings were obtained in the cell-attached patch configuration (Hamill et al., 1981) at a membrane potential of Ϫ70 mV and at 20°C, essentially as described previously (Rayes et al., 2005; Bouzat et al., 2008) . The bath solution (BS) contained the following (in mM):142 KCl, 5.4 NaCl, 1.8 CaCl 2 , 1.7 MgCl 2 , and 10 HEPES, pH 7.4. All pipette solutions were made directly from BS by adding 1000ϫ concentrated stock solutions of ACh in BS and PNU in DMSO. Pipette solutions not containing PNU had the equivalent volume of DMSO added to ensure that all pipette solutions contained a final concentration of 0.1% (v/v) DMSO. Pipette solutions were aliquoted and stored at Ϫ80°C until immediately before each experiment. Patch pipettes were pulled from glass capillary tubes (No.7052, Garner Glass) and coated with Sylgard (Dow Corning). Single-channel currents were recorded using an Axopatch 200B patch-clamp amplifier (Molecular Devices) and digitized at 50 kHz with an InstruTECH ITC-16 interface (Heka Elektronik). Open and closed times were determined using the program TAC 4.2.0 (Bruxton), which digitally filters the data (Gaussian response, final effective bandwidth, 10 kHz), interpolates the digitized points using a cubic spline function and detects events using the half-amplitude threshold criterion as described (Colquhoun and Sigworth, 1983) . Dwell time histograms were plotted using a logarithmic abscissa and a square root ordinate (Sigworth and Sine, 1987 ) with a uniformly imposed dead time of 18 s and fitted by the sum of exponentials by maximum likelihood using the program TACFit 4.2.0 (Bruxton Corporation). Clusters of openings were identified as a series of closely spaced openings preceded and followed by closed intervals longer than a specified critical duration ( crit ). This duration was taken as the point of intersection between consecutive components in the closed time histogram and ranged between 1 and 10 ms. Thus, to determine the dwell time of each cluster, the total time of a series of opening events was combined with that of the intervening closing events briefer than crit .
For the PNU adding experiments (see Figs. 1b,c, 6a ), cells were bathed in 0.7 ml of BS, and a G⍀ seal was formed in the cell-attached patch as described previously (Sine et al., 1995) . Briefly, transfected cells were harvested by gentle agitation in phosphate-buffered saline, centrifuged at 1000 ϫ g for 1 min, and resuspended in potassium Ringer's solution (140 mM KCl, 5.4 mM NaCl, 1.8 mM CaCl 2 , 1.7 mM MgCl 2 , 25 mM HEPES, and 30 mg/L bovine serum albumin, adjusted to pH 7.4) with or without 3 M PNU. For experiments with PNU, the concentration of PNU was maintained at 3 M throughout. The total number of binding sites was determined by incubating cells with 25 nM ␣-BTX for 1 h and subtracting a blank determined in the presence of 1 mM d-tubocurarine. After computing fractional occupancy from the initial rates of toxin binding (Sine and Taylor, 1979) , the following equation was fitted to the data: 
Results
PNU potentiation at the macroscopic and single-channel levels Application of 100 M ACh to human ␣7 ACh receptors (AChRs) expressed in HEK 293 cells elicits small and rapidly decaying macroscopic currents (Fig. 1a) . Both the low amplitude and rapid decay have been explained by termination of the ␣7 openings by unusually rapid desensitization (Bouzat et al., 2008) . When the same cell is preincubated with 3 M PNU, ACh elicits a much greater peak current that decays only partially over the time of agonist application. These results, obtained with HEK 293 cells, agree well with those previously reported for ␣7 AChRs expressed in Xenopus oocytes and isolated neurons (Hurst et al., 2005; Grønlien et al., 2007; Ng et al., 2007; Bertrand et al., 2008; Young et al., 2008; Ló pez-Hernández et al., 2009; Papke et al., 2009; Sattelle et al., 2009) .
While previous studies suggest PNU alters mean channel open time (Hurst et al., 2005) , the macroscopic effects of PNU could result from an increased frequency of channel-opening events. To distinguish between changes in opening frequency and changes in open time, we examined ACh-evoked single-channel currents recorded from the same patch before and after adding PNU. Application of 100 M ACh in the cell-attached patch configuration triggers brief and infrequent singlechannel openings (Fig. 1c) . Subsequent application of PNU (3 M) to the extracellular solution elicits, within minutes, an increase in brief openings succeeded by multisecond-long clusters of singlechannel openings (Fig. 1b,c) . This simple graphic depiction of PNU potentiation at the microscopic/single-channel level demonstrates that increased channel open duration underlies the macroscopic manifestations of PNU.
To quantify the action of PNU at the single-channel level, we examined dwell time histograms generated from recordings obtained in the presence of ACh and increasing concentrations of PNU (Fig.  2) . In the presence of ACh alone, open time histograms are described by the sum of two exponential components, the briefest of which approaches the resolution limit of the patch-clamp apparatus (Fig.  2a) . As a result, openings briefer than the dead time are not fully resolved and thus appear with submaximal current amplitudes. Inspection of the current traces reveals an apparent third component of openings, corresponding to several openings separated by brief closings. These infrequent opening episodes are unmasked by constructing cluster duration histograms in which successive openings are combined with closings briefer than a defined critical time, crit , to form clusters (Materials and Methods) and yielded three exponential components of clusters.
In the presence of 100 M ACh and 0.1 M PNU, open duration and cluster duration histograms shift toward longer durations and are described by the sum of three and four components, respectively (Fig. 2a) , demonstrating that even at a concentration well below its EC 50 (see Fig. 6c ), PNU prolongs ␣7 openings. At 0.3 M PNU (ϳEC 50 ), more profound potentiation becomes obvious from the appearance of multisecond long clusters. Briefer 10 -100 ms and subsecond clusters are also apparent, as are brief unpotentiated events. The appearance of longer potentiated openings further expands the open duration histogram, which is described by the sum of four exponential components. The component with longest mean duration originates from openings that occur exclusively within clusters, giving rise to a fifth component in the cluster duration histogram. Raising the PNU concentration to 3 M, a concentration that maximally potentiates (see Fig. 6c ), increases both the frequency and duration of clusters, which coalesce into superclusters lasting from ten to several hundred seconds. The appearance of superclusters coincides with an increase in the relative area of the corresponding openings, eclipsing that of unpotentiated events, as well as an increase in the relative area of the longest component of clusters.
At the level of macroscopic currents, PAMs have been reported to increase agonist potency (Hogg et al., 2005; Hurst et al., 2005; Bertrand and Gopalakrishnan, 2007) . To determine whether PNU increases agonist potency at the single-channel level, we examined the relationship between agonist concentration and PNU potentiation. Comparing open time histograms obtained at either 10 or 100 M ACh in the presence of PNU (0.3 or 3 M PNU) reveals longer openings at the lower agonist concentration, suggesting PNU potentiation depends on agonist concentration (Fig. 2a,b) . However, longer openings at 10 M ACh likely arise from reduced open channel block by ACh, accounting for the increased open time and the decreased relative area of brief closings. Cluster duration histograms are insensitive to these blocking events because by design, closings briefer than a defined crit are combined with the flanking openings. Accordingly, cluster duration histograms obtained at the different ACh concentrations show essentially no difference in the mean durations or relative areas of potentiated and unpotentiated events, which was also apparent from inspection of the single-channel traces. In fact, 1 M ACh, a concentration that triggers only rare openings in the absence or presence of PNU, still elicits multisecond-long clusters in the presence of 3 M PNU (Fig. 2c) . Despite a low number of total events at 1 M ACh, cluster duration histograms show that the relative proportion of potentiated and unpotentiated events is essentially the same as that at 10 and 100 M ACh. Thus, agonist concentration does not affect the relative proportion of potentiated and unpotentiated events, and at the single-channel level PNU potentiation does not depend on ACh concentration.
Structural determinants of PNU potentiation
Previous studies identified several residues within the transmembrane domain of rat ␣7 crucial for PNU potentiation (Young et al., 2008) . Two mutations in particular, A225D and M253L (A226 and M254 in human ␣7), reduced PNU potentiation of macroscopic currents by ϳ90%. We therefore examined how these mutations affected PNU potentiation at the microscopic/singlechannel level. When installed in human ␣7, the A226D mutation abolished surface expression in HEK 293 cells, but the mutant A226S expressed well, as did M254L. To our surprise, in the presence of 3 M PNU, receptors with either of these substitutions still give rise to unmistakable multisecond-long clusters (Fig. 3) , as do receptors containing both mutations (A226SϩM254L; SL). Both open duration and cluster duration histograms show that compared to wild-type ␣7, the ratio of potentiated to unpotentiated events is lower in each of the three mutants. Thus A226S and M254L do not abolish clusters, but instead reduce their frequency of occurrence relative to unpotentiated events.
Given that A226 and M254 are not the sole determinants of PNU potentiation, we hypothesized that nearby residues also contribute to the putative PNU site. Thus, we introduced additional substitutions into the double mutant background and examined potentiation by PNU. Of the many triple mutants initially screened (Table 1) , two further decreased potentiation (SLϩI281M and SLϩV288F), although both I281M and V288F by themselves only marginally reduced potentiation (Fig. 4) . However, in the presence of 100 M ACh and 3 M PNU, both triple mutants still exhibited multisecond-long clusters. Thus we combined I281M and V288F into the double mutant to form the quadruple mutant (SLMF). The SLMF mutant reduced potentiation to the point where clusters were even briefer and less frequent (Fig. 4) . Based on open duration and cluster duration histograms, 3 M PNU potentiated the SLMF mutant comparable to 0.3 M PNU applied to wild-type ␣7, indicating roughly a 10-fold decrease in PNU potency.
Buoyed by the further reduction in cluster duration and frequency of the quadruple mutant, we screened additional mutations on the SLMF mutant background (Table 1) . Combining the mutation S223T to form the quintuple mutant (TSLMF) abolished clusters at 3 M PNU (Fig. 5) . Despite the structural similarity between the Ser and Thr side chains, the S223T mutant by itself reduced potentiation to a similar extent as the quadruple (SLMF) mutant. Given the marked reduction of potentiation by S223T, we tested different side chains at this position. Substitution of larger and bulkier residues (S223T and S223V) reduced PNU potentiation, whereas substitution of the smaller alanine (S223A) had little effect (Fig. 5) . Thus, side chain volume at position 223 appears important for PNU potentiation.
To further illustrate the profound reduction in PNU potentiation by the quintuple mutant (TSLMF), we performed a PNU adding experiment akin to that in Figure 1 for wild-type ␣7. Whereas addition of 3 M PNU to an active cell-attached patch of wild-type receptors results in multiple superimposed clusters, addition of PNU to a comparable patch of quintuple mutant receptors has no noticeable effect (Fig. 6a) . This insensitivity to PNU was confirmed by whole-cell recordings in which preincubation with 3 M PNU had little effect on the magnitude and duration of the agonist-evoked response (Fig. 6b) . To quantify the decrease in potentiation by the TSLMF mutant, we constructed a single-channel PNU dose-response relationship, plot- 
Bold indicates individual mutations combined to make the quintuple TSLMF mutant. The abbreviation wt is wild type.
ting the ratio of the number of potentiated to total events based on fitted exponential components in open time histograms as a function of PNU concentration (Fig. 6c) . For wild-type ␣7, the EC 50 was 0.28 M (95% confidence interval, 0.22-0.35 M), in accord with previous measurements (Hurst et al., 2005) , whereas for the quintuple mutant the EC 50 was ϳ17 M (95% confidence interval, 12.5-23.1 M). Thus, the TSLMF mutant is not potentiated by concentrations of PNU up to 3 M and is only marginally potentiated at 10 M PNU, a concentration approaching the solubility limit of PNU in our buffer solution.
We also examined the ability of PNU to allosterically alter agonist binding affinity through measurements of ACh competition against the initial rate of radio-labeled ␣-BTX binding (Fig. 6d) . In the case of wild-type ␣7, 3 M PNU increases apparent affinity for ACh, whereas the quintuple TSLMF mutant is unaffected. Thus, our overall data show that 3 M PNU, a concentration that maximally potentiates wild-type ␣7 receptors (see Fig. 6c ), does not potentiate the quintuple TSLMF mutant.
Discussion
Our single-channel recordings from neuronal ␣7 AChRs show that PNU potentiates agonist-induced responses by prolonging individual channel openings and, further, by condensing these openings into clusters of many openings in quick succession. Two kinetic classes of prolonged openings and clusters are observed, with the first and briefer class predominating at low and intermediate PNU concentrations and the second and longer class predominating at high concentrations. The two brief kinetic classes of ␣7 openings without PNU are prolonged ϳ3000-to 30,000-fold by high PNU concentrations. Thus, rather than increasing the frequency of individual activation episodes, PNU increases the mean duration and number of openings per activation episode. By combining single-channel recording with mutagenesis, we provide evidence that a transmembrane region within each ␣7 subunit is required for PNU potentiation, and we identify novel determinants within this region. At the single-channel level, ␣7 AChRs activate predominantly as single brief openings flanked by long closed periods. The mean duration of these openings coincides with the time constant for desensitization determined by rapid application of agonist to out-side-out patches (Bouzat et al., 2008) . Thus channel openings of the ␣7 AChR are unusual in that they terminate by desensitization rather than by return to a closed, activatable state. Termination via desensitization explains why, at high agonist concentrations, openings of the ␣7 AChR do not form clusters of many openings in quick succession and, further, why the kinetics are independent of agonist concentration. Our singlechannel studies show that the most pronounced effect of PNU corresponding to two deep energy basins, each flanked by large energy barriers. Previous macroscopic current measurements showed an increase in agonist potency in the presence of PNU (Hurst et al., 2005) . However, we find that for a given concentration of PNU, distributions of single-channel cluster durations are independent of the agonist concentration. In whole-cell measurements, noninstantaneous agonist perfusion, combined with rapid desensitization, underestimates the true EC 50 for activation (Papke and Thinschmidt, 1998) . Because PNU markedly slows desensitization, a limited agonist perfusion rate does not affect the measured EC 50 in the presence of PNU, potentially accounting for the apparent increase in agonist potency.
Previous whole-cell experiments identified multiple transmembrane residues important for PNU potentiation (Young et al., 2008) . These residues line an internal cavity between the four transmembrane helices (TM1-4) of a single subunit. Our singlechannel data show that mutation of any of these residues individually does not eliminate PNU potentiation. Instead combination of multiple mutations progressively reduces potentiation. We identified five substitutions that cluster in and around this cavity (Figure 7 ) that, when combined, almost completely abolish potentiation at a high concentration of PNU. Of all the individual substitutions we made, the relatively conservative mutation S223T had the largest effect. This same substitution is found in the Caenorhabditis elegans homolog of human ␣7 called ACR-16, which despite having 47% sequence identity is not potentiated by PNU (Sattelle et al., 2009) . In fact, ACR-16 has substitutions at all five positions mutated in our quintuple mutant, three of which are identical to the substitutions we arrived at independently in our screening (S223T, M254L, and V288F).
While our findings are consistent with an intrahelical PNU binding site, we emphasize two points of caution. First, we selected our mutations by assuming that residues lining the interhelical cavity contribute to PNU binding, and thus our data cannot be considered de novo evidence supporting a PNU binding site. Second, mutagenesis experiments cannot rule out indirect allosteric effects. Thus, unequivocal localization of the PNU binding site awaits direct evidence from structural or chemicallabeling studies. However, mounting evidence suggests that this intrahelical cavity may be a general modulatory site within the Cys-loop receptor superfamily. Anesthetics, alcohols, and neurosteroids are thought to bind to a similar location in GABA and glycine receptors (Belelli et nearby residues in the Torpedo AChR (Arevalo et al., 2005; Garcia et al., 2007; Hamouda et al., 2011) . Furthermore, x-ray structures of a prokaryotic homolog show general anesthetics interacting with residues lining the cavity walls (Nury et al., 2011) . The presence of an intrahelical binding site within a subunit contrasts with the intersubunit site for the PAM ivermectin revealed in the crystal structure of a glutamate-activated Cys-loop receptor (Hibbs and Gouaux, 2011) .
If this intrahelical cavity is the PNU binding site, it immediately suggests a physical mechanism by which PNU alters desensitization kinetics. Channel opening and closing result from structural rearrangements of the transmembrane helices, with particular emphasis on TM2, which lines the channel pore. In the process of knocking down potentiation, we found that several substitutions altered mean channel open times in the absence of PNU. While these changes are small compared to the effects of PNU, they show that the chemical identity of residues lining the interhelical cavity affect open channel lifetime, and thus the rate of ␣7 desensitization. Spacing and interactions between transmembrane helices likely determine energy barriers controlling their movements, and by occupying a space that is normally vacant, PNU may present a steric barrier to helical movements required for desensitization. Analogously, substitutions that introduce bulkier side chains, effectively filling the interhelical cavity, may have a similar effect while at the same time occluding PNU binding. Thus, our findings provide a mechanistic and structural framework to understand channel opening, desensitization, and potentiation of neuronal ␣7 AChRs at the singlemolecule level.
